Prolonged Inadequate Sleep Linked to Obesity and Diabetes

Share this content:
Prolonged Inadequate Sleep Linked to Obesity and Diabetes
Prolonged Inadequate Sleep Linked to Obesity and Diabetes

(HealthDay News) – Prolonged inadequate sleep at irregular times lowers the resting metabolic rate and leads to defects in pancreatic insulin secretion, increasing the risk for obesity and diabetes.

Orfeu M. Buxton, PhD, and colleagues from Brigham and Women's Hospital in Boston, studied the metabolic consequences of three weeks of sleep restriction (5.6 hours per 24 hours) combined with circadian disruption. The study followed a baseline period of optimal sleep by the 21 healthy adult participants.

The researchers found that sleep restriction and circadian disruption led to a lower resting metabolic rate. This was also associated with increased plasma glucose concentrations after meals, which was due to a 32% drop in pancreatic insulin secretion. However, these parameters normalized after nine days of recovery sleep at the usual times.

"Thus, in humans, prolonged sleep restriction with concurrent circadian disruption alters metabolism and could increase the risk of obesity and diabetes," Buxton and colleagues conclude.

Several authors disclosed financial ties to the pharmaceutical, publishing, and medical technology industries; one author has served as an expert witness in a case involving sleep, circadian rhythms, and diabetes.

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs